About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Insulin Treatment in Patients with Type 2 Diabetes: When to Use Combination Therapy
By
Emory Diabetes Education Training Academy
FEATURING
Guillermo Umpierrez
May 15, 2020
5 Comments
Login to view comments.
Click here to Login
Featured Video
19:47
Novo Nordisk – GLP-1 RA Therapy
GLP-1 RA Use in Clinical Practice: Examining Trial Data and T2D Trea…
Feat.
L. Coco,
C. Solis-Herrera
Featured Video
07:57
Novartis Cardiology
Clinical Trial Data Overview: LDL-C Reduction in Patients with ASCVD…
Feat.
A. Brown
Related Content
AUTOPLAY
ON
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments
Primer on Diabetes Management
Feat.
S. Inzucchi
47:11
Houston Methodist Hospital
The Protein Myth: Our Obsession With Protein and How It Is Killing US
Feat.
G. Davis
49:21
Physicians Committee for Responsible Medicine
Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…
Feat.
T. J. Key
11:37
ACC 2022 Conference Coverage
ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…
Feat.
P. Heidenreich
11:25
ACC 2023 Conference Coverage
ACC 2023: SGLT2i Use - Dos and Don'ts
Feat.
A. Armbruster
18:43
ASPC 2019 Congress on CVD Prevention
Diabetes Treatment Guidelines Finally Have Entered the 21st Century …
Feat.
R. DeFronzo
23:35
Practical Ways to Achieve Targets in Diabetes Care
Is There a Future for HbA1c? (Moving Towards CGM: GMI and TIR)
Feat.
I. Hirsch
26:01
Cardiology Fiesta 2017
Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…
Feat.
R. DeFronzo
12:26
Juan Frias
SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide
15:33
Ken Fujioka
Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…
17:44
Rita Jermyn
SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease
27:24
Cardiometabolic Health Congress (CMHC)
SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes
Feat.
L. Sloan
37:21
University of Colorado Department of Medicine
Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…
Feat.
R. Johnson
20:24
Diana Isaacs
Tirzepatide for Type 2 Diabetes
26:06
University of Virginia School of Medicine and School of Nursing
Practical Tips on Use of GLP-1 and GIP Receptor Agonists
Feat.
W. Horton
26:32
Practical Ways to Achieve Targets in Diabetes Care
Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity
Feat.
S. Nissen
30:08
Stanford Medicine
Animal vs. Vegetable: Does Food Type Matter?
Feat.
C. Gardner
19:30
ACC 2022 Conference Coverage
Hot Topics in Heart Failure ACC.22
Feat.
N. Ibrahim
24:19
University of Virginia School of Medicine and School of Nursing
GLP1-Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes: How …
Feat.
E. Barrett
18:05
The Texas Heart Institute
Inside the Studio w/ Dr. Stephanie Coulter | Dr. Darren McGuire
Feat.
S. Coulter,
D. K. Mcguire